Note: Accelerate^® Concentrating System has not been evaluated by the FDA for specific therapeutic indications.

• High Platelet Yields – Gentle centrifugal acceleration isolates the buffycoat. Gentle deceleration preserves this layer of highly concentrated platelets from plasma and red blood cells. The high yield of platelets may then be siphoned off the top of the buffycoat.
• Sterility – The patient’s blood is collected into a sterile tube, processed in the centrifuge, and piped into the sterile field through a closed system. Only two sterile-barrier entries are required—the least of any PRP concentrating system available today.
  Accelerate also eliminates the possibility of transfer contamination. Once processed, the PRP and PPP are piped directly into the sterile field. This eliminates the potential for contamination that exists when a circulating nurse is required to manually transfer PRP and PPP into the surgical field.
• Flexible & Convenient – Accelerate can effectively process 30-240ml of blood via a single, 12-minute spin. Light and portable, the centrifuge may easily be transferred among operating rooms.
• Cost Effective – In total knee arthroplasty, surgeons have reported a reduced need for blood transfusion and elimination of drains and peripheral equipment.^2,3,4 Reduced hospital stay and pain medication are also potential benefits from the effective use of PRP.^3,4
  

Applications of PRP

PRP has global applications in a variety of surgical procedures including total joint replacement, bone repair and facial cosmetic and reconstructive surgery. Its ability to speed healing and improve patient outcomes has been well documented.¹

Recently the use of PRP in knee surgery has received considerable attention, prompting several published papers.^2,3,4

References

1. Pietrzak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005 Nov;16(6):1043-54.

2. Everts PA, Devilee RJ, et al. Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty. Acta Anaesthesiol Scand. 2006 May;50(5):593-9.

3. Gardner MJ, Demetrakopoulous D, et al. The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty: An analysis of the hemoglobin, narcotic requirement and range of motion. Int Orthop. 2006 Jul 1.

4. Bertram M. Reducing blood loss in total knee replacement. Presentation at the Platelet Gel Symposium, Sanibel Island Spa and Resort. Oct. 2006.